Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pharma-Bio Serv (PBSV) Return on Equity (2016 - 2026)

Pharma-Bio Serv (PBSV) has disclosed Return on Equity for 12 consecutive years, with 0.03% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Equity rose 2.0% year-over-year to 0.03%, compared with a TTM value of 0.03% through Oct 2025, up 2.0%, and an annual FY2025 reading of 0.01%, up 4.0% over the prior year.
  • Return on Equity was 0.03% for Q4 2025 at Pharma-Bio Serv, down from 0.03% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.13% in Q3 2021 and bottomed at 0.25% in Q3 2022.
  • Average Return on Equity over 5 years is 0.01%, with a median of 0.02% recorded in 2024.
  • The sharpest move saw Return on Equity crashed -38bps in 2022, then skyrocketed 34bps in 2023.
  • Year by year, Return on Equity stood at 0.1% in 2021, then skyrocketed by 169bps to 0.07% in 2022, then grew by 8bps to 0.07% in 2023, then tumbled by -178bps to 0.06% in 2024, then surged by 40bps to 0.03% in 2025.
  • Business Quant data shows Return on Equity for PBSV at 0.03% in Q4 2025, 0.03% in Q3 2025, and 0.03% in Q2 2025.